L-Arginine in coronary atherosclerosis

被引：24
|
作者：
Tentolouris, C
Tousoulis, D
Goumas, G
Stefanadis, C
Davies, G
Toutouzas, P
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit, GR-11527 Athens, Greece
[2] Imperial Coll, Sch Med, Hammersmith Hosp, Cardiol Unit, London, England
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2000年 / 75卷 / 2-3期
关键词：
endothelium; nitric oxide; atherosclerosis; L-arginine;
D O I：
10.1016/S0167-5273(00)00320-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nitric oxide is formed from the N-guanido terminal of the amino acid L-arginine and from molecular oxygen by nitric oxide synthase enzymes. L-arginine administration improves the coronary blood flow response to acetylcholine in patients with normal coronary arteries and hypercholesterolemia, reverses the defective endothelium-dependent vasodilation associated with an elevated plasma low-density lipoprotein level or hypercholesterolemia, dilates coronary epicardial arteries and stenoses, enhances nitric oxide generation, and inhibits lesion formation after balloon angioplasty. Stimulation of endogenous nitric oxide production could inhibit atherogenesis, and therefore may be of benefit in patients with risk factors for atherosclerosis. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：123 / 128
页数：6
相关论文
共 50 条
  • [41] Effects of vitamin C on nitric oxide/L-arginine pathway in patients with atherosclerosis
    Tousoulis, D
    Davies, G
    Tentolouris, C
    Tousoulis, G
    Goumas, G
    Xenakis, C
    Pitsavos, C
    Brilli, S
    Antoniades, C
    Stefanadis, C
    Toutouzas, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 253A - 253A
  • [42] Crystal structure and characterization of L-arginine dichloride monohydrate and L-arginine dibromide monohydrate
    Petrosyan, AM
    Karapetyan, HA
    Bush, AA
    Sukiasyan, RP
    MATERIALS CHEMISTRY AND PHYSICS, 2004, 84 (01) : 79 - 86
  • [43] REGULATION OF MACROPHAGE PHYSIOLOGY BY L-ARGININE - ROLE OF THE OXIDATIVE L-ARGININE DEIMINASE PATHWAY
    ALBINA, JE
    MILLS, CD
    HENRY, WL
    CALDWELL, MD
    JOURNAL OF IMMUNOLOGY, 1989, 143 (11): : 3641 - 3646
  • [44] L-arginine infusion dilates coronary vasculature in patients undergoing coronary bypass surgery
    Wallace, AW
    Ratcliffe, MB
    Galindez, D
    Kong, JS
    ANESTHESIOLOGY, 1999, 90 (06) : 1577 - 1586
  • [45] How much L-arginine to counteract L-arginine deficiency?: Response from authors
    O'Brien, T
    JOURNAL OF VASCULAR RESEARCH, 1999, 36 (06) : 533 - 534
  • [46] CORRECTION OF ENDOTHELIAL DYSFUNCTION IN CORONARY MICROCIRCULATION OF HYPERCHOLESTEROLEMIC PATIENTS BY L-ARGININE
    DREXLER, H
    ZEIHER, AM
    MEINZER, K
    JUST, H
    LANCET, 1991, 338 (8782-3): : 1546 - 1550
  • [47] Oral L-arginine in patients with coronary artery disease on medical management
    Blum, A
    Hathaway, L
    Mincemoyer, R
    Schenke, WH
    Kirby, M
    Csako, G
    Waclawiw, MA
    Panza, JA
    Cannon, RO
    CIRCULATION, 2000, 101 (18) : 2160 - 2164
  • [48] Growth and dielectric properties of L-arginine acetate and L-arginine oxalate single crystals
    Meena, M.
    Mahadevan, C. K.
    MATERIALS LETTERS, 2008, 62 (21-22) : 3742 - 3744
  • [49] L-arginine restores coronary endothelial function in obese Zucker rats
    Jackson, KE
    Durante, W
    Peyton, KJ
    Johnson, RA
    Johnson, FK
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S265 - S265
  • [50] L-arginine ameliorates dysfunctional coronary endothelial responses to adrenergic stimulation
    Gellman, J
    Hare, JM
    Lowenstein, CJ
    Gerstenblith, G
    Coombs, V
    Brinker, JA
    Resar, JR
    CIRCULATION, 1997, 96 (08) : 1762 - 1762
12345